Clinical Trials Browser

Phase 1 × Leukemia × pembrolizumab × Clear all

NCT03219450 2026-05-28

A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Lymphoid